The B-myb gene is expressed In many cell ypes at the G1/S transition of the cell cycle. Inhibition of B-myb expression in BALB/c 3T3 fibroblasts by introduction of a B-myb antisense construct greatly di d cl proliferation, whereas constitutive expression of a human B-myb cDNA in these cells reduced their growth factor requirements and induced a transformed phenotype. Constitutive expression ofB-myb cDNA was accompanied by activation ofcycdin D1 and cdc2 expression but not of cyclin A and cyclin B. Transfection of BALB/B-myb cells (a cell line expressing levels of exogenous human B-myb) with a cyclin D1 antisense construct drastically reduced cloning efficiency of these cells. These results suggest that the B-myb-encoded product regulates fibroblast proliferation by activating cdc2 and cyclin D1 gene expression and that abnormal expression of cyclin D1 might be a step in the process of transformation.
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The A-myb and B-myb genes, which are related to the protooncogene c-myb, the cellular homolog of the transforming gene of the avian myeloblastosis virus, and the avian leukemia virus E26, which cause myeloblastic leukemia in chickens and transform myelomonocytic hematopoietic cells in culture (1, 2) , have been isolated.
Recent evidence suggests that c-myb plays an important role in the regulation of normal and leukemic hematopoiesis and T-lymphocyte proliferation (3) (4) (5) (6) (7) . Inhibition of c-myb expression prevents G1/S transition in leukemic cell lines and normal T lymphocytes and is associated with selective downregulation of DNA polymerase a expression (8) , suggesting the direct involvement of c-myb in an essential biochemical pathway leading to DNA synthesis. Moreover, constitutive expression of human c-myb in murine fibroblasts abrogates the requirement for the cell cycle progression factor insulinlike growth factor 1 (9), suggesting a general role for c-myb in cellular proliferation.
B-myb is homologous to c-myb in the DNA binding domain, and its pattern of expression is not restricted to hematopoietic cells (10) . In fact, B-myb transcripts have been detected in the majority of cell lines and tissues tested (10) . Recent studies have shown that, like c-myb, B-myb acts as a transactivating factor; in transient expression assays, a constitutively expressed B-myb cDNA transactivates a reporter gene linked to the simian virus 40 (SV40) early promoter and enhancer through interaction ofthe encoded protein with B-myb binding sites in the SV40 early promoter (11) .
B-myb is also expressed in BALB/c 3T3 fibroblasts at the G1/S boundary with kinetics similar to that of c-myb in phytohemagglutinin-stimulated normal T lymphocytes (12, 13) . Inhibition of B-myb expression by low concentrations of the protein synthesis inhibitor cycloheximide and at the restrictive temperature in Gl-specific temperature-sensitive mutants of the cell cycle (13) supports the notion that B-myb is growth-regulated at the G1/S boundary. Because c-myb is not expressed at detectable levels in fibroblasts, we asked whether B-myb might be the functional equivalent of c-myb in regulating proliferation in nonhematopoietic cells. We used the model system of BALB/c 3T3 fibroblasts to study cell proliferation because they have a well-defined growth factor requirement (14, 15) , which allows determination of the stage in the Go/S transition that requires B-myb function. We report here that B-myb is needed for BALB/c 3T3 proliferation, perhaps by selectively activating the expression of cdc2 and cyclin D1 genes.
MATERIALS AND METHODS
Cloning of a Full-Length B-myb cDNA. The full-length B-myb cDNA was cloned as follows. A human lymphoma cDNA library cloned in the Agtll vector was screened with a 1.4-kilobase radiolabeled B-myb fragment (10) . The longest recombinant phage was used to release a 1469-base-pair (bp) fragment spanning the EcoRP site 3' of the polyadenylylation signal to an EcoRI site at nucleotide 1161 of the published B-myb cDNA sequence. This fragment was subcloned into an SK plasmid vector (Stratagene). The remaining 5' portion of the cDNA was cloned by PCR amplification of reversetranscribed B-myb mRNA from HL-60 cells. The cloning reaction was carried out in three different steps:
(i) B-myb cDNA extending from nucleotide 749 to nucleotide 1235 was amplified and subcloned into an Sma I-digested SK vector and ligated to the previously subcloned B-myb by utilizing a Ban I site (nucleotide 1219).
(ii) A longer B-myb segment extending from nucleotide 197 to nucleotide 1127 was amplified and subcloned into an Sma I-digested SK vector. Ligation of the two B-myb portions at an Xho I site (nucleotide 743) resulted in a B-myb clone that lacked the fist 69 bp starting from the ATG initiation site.
(iii) Two oligomers covering the remaining portion of the cDNA were synthesized since amplification of this portion by PCR was unsuccessful. The B-myb cDNA segments obtained by PCR or by synthetic oligomers were sequenced and found to be identical to the published sequence. The full-length B-myb cDNA was subsequently eluted from the SK vector (pSKB-mybl), digested with Cla I and Xba I, and subcloned into the pSV40 polylinker vector, which contains a polycloning site located between the pSV40 early promoter and the SV40 polyadenylylation signals, and designated pSV/B-myb.
Cloning of an Antisense B-myb Construct. (17) .
RNA Blots. RNA was extracted by the method of Chomczynski and Sacchi (18) and analyzed on RNA blots by the method of Thomas (19) .
Reverse Transcriptlon-PCR Phenotyping of BALB/B-myb Cells. Levels of cyclin A, cyclin B, cyclin D1, cdc2, and 1-actin mRNAs were measured by reverse transcription-PCR as described (8) , except that cyclin A and cyclin B amplifications were achieved at the annealing temperature of 3TC. The cyclin A 5' primer (nucleotides 753-770 of human cyclin A cDNA) was 5'-GACTGGTTAGTTGAAGTA-3'; the 3' primer (nucleotides 975-992) was 5'-CTCCATTCT-CAGAACTTG-3'; the oligonucleotide probe extended from nucleotide 861 to nucleotide 884; all are from the published sequence (20) . The cyclin B 5' primer (nucleotides 780-797 of the human cyclin B cDNA) was 5'-TAGTTCCATCAGG-TATTTGGC-3'; the 3' primer (nucleotides 1201-1221) was 5'-TAGTTCCATCAGGTATTTGGC-3'; the oligonucleotide probe extended from nucleotide 1141 to nucleotide 1164; all are from the published sequence (21) . The cyclin D15' primer (nucleotides 590-613 of mouse cyclin D1 cDNA) was 5'-GAGGAGCTGCTGCAAATGGAACTG-3'; the 3' primer (nucleotides 773-793) was 5'-CATGGAGGGTGGGTTG-GAAAT-3'; the diagnostic oligomer probe extended from nucleotide 659 to nucleotide 688; all are from the published sequence (16) . The cdc2 5' primer (nucleotides 54-75) was 5'-GGAGAAGGTACCTATGGAGTTG-3'; the 3' primer (nucleotides 307-328) was 5'-GAATCCATGTACTGAC-CAGGAG-3'; the synthetic probe was from nucleotide 147 to nucleotide 167; all are from the published sequence (22) . The P-actin 5' primer (nucleotides 224-244) was 5'-TGG-GAATGGGTCAGAAGGACT-3'; the 3' primer (nucleotides 412-433) was 5'-TTTCACGGTTGGCCTTAGGGTT-3'; the synthetic probe was from nucleotide 258 to nucleotide 236; all are derived from the published sequence of mouse (3-actin cDNA (23) .
In Vitro Transcription and Translation of B-myb cDNA. The plasmid template (pSKB-mybl) was linearized either by Not I or by EcoRV restriction enzymes to obtain the sense or the antisense B-myb mRNA, respectively. Capped mRNA was synthesized by using 17 hygromycin-containing medium revealed a drastically reduced number of hygromycin-resistant colonies (90%o inhibition) as compared to BALB/c 3T3 cells transfected with the vector only (Fig. 1) . This experiment was repeated three times with different plasmid preparations; furthermore, levels of the endogenous B-myb transcripts were barely detectable in residual B-myb antisense transfectants (Fig. 2) . Together, the data suggest a specific effect of the B-myb antisense construct on cell proliferation and indicate that B-myb is required in normal fibroblast proliferation. Growth Characteristics of BALB/c 3T3 Cells Constitutivel
Expressing B-myb. To examine the effects of B-myb constitutive expression on the growth of BALB/c 3T3 cells, a cell line (BALB/B-myb) expressing high levels of exogenous human B-myb was established by transfecting those cells with the plasmid pSV/B-mybl. Under high-stringency hybridization conditions, a positive signal corresponding to the human B-myb mRNA was detected with the human probe in lanes containing RNAs derived from BALB/B-myb and HL-60 cells, but not from the parental BALB/c 3T3 cells (Fig. 3A) . Antibodies against the B-myb protein are still not available, so detection of the B-myb protein in transfected cells is precluded. However, to determine whether our construct would at least be translated in vitro, RNA transcribed from the construct pSKB-mybl was incubated in vitro with a reticulocyte lysate; a protein of about 80 kDa was generated hygromycin-containing DMEM (250 pg/ml), mixed cell populations or single clones were picked up and maintained in culture under the same conditions of selection. RNAs from transfected cell lines and HL-60 cells were obtained as described (18) . Total cellular RNA (10 gg) was electrophoresed in an agarose/formaldehyde gel, transferred to nylon filters, and hybridized to a radiolabeled human B-myb cDNA fragment as described (19 ( Fig. 3B) , which is in good agreement with the size predicted from the cDNA sequence. To determine whether B-myb expression could alter the growth characteristics of the transfected cells, we plated BALB/B-myb and control BALB/c 3T3 cells transfected with the pSV40 vector lacking the B-myb cDNA in medium containing 1% serum, which induces entry into a quiescent state. After 9 days of culture, the number of BALB/B-myb cells was significantly higher than that of the control cells (412 x 104 cells per well in 24-well plates for BALB/B-myb as compared to -3 x 104 cells of BALB/c 3T3 transfected with the vector alone), indicating that BALB/B-myb cells can still proliferate in low serum conditions, although at a reduced rate (doubling time of48 hr in 1% serum as compared to 24 hr in 10% serum). The reduced serum requirements of randomly picked single clones from different transfections correlated well with mRNA levels of exogenous B-myb, as indicated by the capacity of clones with high B-myb expression to grow in 1% serum (Fig. 4 A and B) , whereas BALB/c 3T3 cells require platelet-derived growth factor and insulin or insulin-like growth factor 1 for survival in serum-free medium. BALB/ B-myb cells not only survived but also grew in serum-free medium, although with a very slow (%96 hr) doubling time (data not shown). To determine whether the growth-factor independence of BALB/B-myb was an indication of progression toward a transformed phenotype, we plated both BALB/B-myb and the parental cells in soft agar. After 10 days of culture, BALB/B-myb cells formed colonies in agar with high efficiency (-50%6), whereas BALB/c 3T3 cells formed small colonies, with an efficiency of only 1-5% (data not shown).
Expression of cdc2 and Cydin Genes in BALB/c 3T3 Cells Constitutively Expressing B-myb. To explore the potential molecular mechanisms associated with the growth factorindependent and transformed phenotype of BALB/B-myb cells, we analyzed the effect of constitutive B-myb expression on cdc2 and cyclin genes since they appear to be important both at the G1/S transition and during mitosis (16, (24) (25) (26) (27) (28) PCR analysis revealed that cdc2 and cyclin D1 mRNA levels were up-regulated in BALB/B-myb clones (Fig. 5A ) and were found to correlate with those of the exogenous human B-myb (Fig. 4B ). In contrast, cyclin A, cyclin B, and f-actin mRNA levels were constant. Even though the PCR results were highly reproducible because few amplification cycles were utilized (20 cycles), we also performed Northern blot hybridization to obtain independent confirmation of changes in cdc2 and cyclin D1 mRNA levels. Fig. 5 B and C shows that cdc2 and cyclin D1 mRNA levels were markedly increased in the BALB/B-myb cell line as compared to the parental BALB/c 3T3 cell line. In contrast, cyclin A and B mRNA levels were constant (not shown). Thus, the effects of constitutive B-myb expression on cdc2 and cyclin D1 expression appear to be specific.
Cloning Efficiency of BALB/B-myb Cells Transfected with an Antisense Cydin D1 Construct. To determine whether cyclin D1 expression was required for the maintenance of the phenotype induced by B-myb, BALB/B-myb cells were transfected with an antisense cyclin D1 construct (10:1 ratio) driven by the SV40 early promoter in the presence ofthe gene encoding the resistance to neomycin. After selection in G418-containing medium, the number of G418-resistant colonies formed after transfection with the cyclin D1 antisense construct was drastically reduced (by -80%) as compared to BALB/B-myb cells transfected with the vector only (Fig. 6) . Levels (28) . In addition, in that model of cell proliferation, cdc2 mRNA expression is a late event and follows the appearance of c-myb mRNA (28); of even greater interest, treatment of phytohemagglutinin-stimulated T lymphocytes with c-myb antisense oligodeoxynucleotides prevents the late induction of cdc2 mRNA expression (28) . Because B-myb has several properties of a potential c-myb equivalent in fibroblast proliferation, the reported functional link between c-myb and cdc2 in T lymphocytes supports our own data ofthe link between B-myb and cdc2 in BALB/c 3T3 fibroblasts. The importance of the B-myb-cyclin D1 functional link was directly demonstrated by the ability ofa cyclin D1 antisense construct to inhibit the cloning efficiency of BALB/B-myb cells (Fig. 6 ). It has been recently shown that cyclin A is required for the onset of DNA replication in mammalian fibroblasts (30) , raising the possibility that the effects seen with the cyclin D1 antisense construct might have been caused by inhibition of cyclin A expression.
Comparison of the DNA sequence of the cyclin D1 segment used in our studies with cyclin A cDNA sequence revealed only a 39%o nucleotide homology (data not shown), which suggests that the antiproliferative effect seen with the cyclin D1 antisense construct was specific. These findings do not exclude the participation of other genes in the regulation of normal fibroblast proliferation by B-myb or in the abnormal growth associated with its constitutive expression. They provide, however, compelling evidence for the essential role of cycin D1. Although the mechanism by which cyclin D1 regulates cell cycle progression is not known, it is likely that the cyclin Dl-encoded protein interacts with and activates the p34cdc2 kinase previously shown to regulate the G1/S transition (28, 31) . Alternatively, cyclin Di-encoded protein could also interact with related members of the cdc2 family, which could also be involved in the regulation of cell cycle progression (16, 32) to regulate the G1/S transition. This would suggest the existence of multiple regulatory networks in cell cycle progression involving members of the cdc2 and cyclin gene family. Finally, our findings support the possibility that cyclin D1 expression plays a direct role in the process of cellular proliferation and might be involved in neoplastic transformation.
